⌘K
Loading ticker…
As of 2026-08-24, Cue Biopharma, Inc. (CUE) has a 3-month relative strength percentile of 63 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 63. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 12.7%, relative volume 0.62×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
CUE is held by 2 ETFs as of May 2026. Top owner: AVSC at 0.00% weight, $7K notional.
Held by 2 ETFs · $7K across latest filings · largest weight 0.00% (AVSC).
Top 2 by value, from SEC N-PORT-P filings dated May 2026.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CUE Jan avg: 15.66% median: 14.81% win: 100% σ: 14.17% n: 4 2022-04-12 → 2026-07-31 | CUE Feb avg: -17.76% median: -17.23% win: 0% σ: 2.71% n: 4 2022-04-12 → 2026-07-31 | CUE Mar avg: -6.32% median: -13.42% win: 25% σ: 23.59% n: 4 2022-04-12 → 2026-07-31 | CUE Apr avg: 19.81% median: 0.53% win: 60% σ: 54.97% n: 5 2022-04-12 → 2026-07-31 | CUE May avg: 1.79% median: -7.62% win: 20% σ: 26.69% n: 5 2022-04-12 → 2026-07-31 | CUE Jun avg: -3.46% median: -8.75% win: 40% σ: 31.04% n: 5 2022-04-12 → 2026-07-31 | CUE Jul avg: -4.74% median: 4.66% win: 60% σ: 18.61% n: 5 2022-04-12 → 2026-07-31 | CUE Aug avg: -7.63% median: -4.76% win: 50% σ: 17.07% n: 4 2022-04-12 → 2026-07-31 (current) | CUE Sep avg: -10.59% median: -11.51% win: 25% σ: 12.23% n: 4 2022-04-12 → 2026-07-31 | CUE Oct avg: 32.50% median: 13.04% win: 75% σ: 54.63% n: 4 2022-04-12 → 2026-07-31 | CUE Nov avg: 5.50% median: 0.56% win: 50% σ: 32.58% n: 4 2022-04-12 → 2026-07-31 | CUE Dec avg: -20.69% median: -18.41% win: 25% σ: 24.31% n: 4 2022-04-12 → 2026-07-31 |